Literature DB >> 20550766

Rapid detection of immunoglobulin G against Mycobacterium tuberculosis antigens by two commercial ELISA kits.

W Ben Selma1, H Harizi, M Marzouk, I Ben Kahla, F Ben Lazreg, A Ferjeni, I Harrabi, A Abdelghani, M Ben Said, J Boukadida.   

Abstract

SETTING: Tunisia.
OBJECTIVE: To assess the clinical usefulness of the commercial Pathozyme-Myco G (Myco G) and Pathozyme TB complex plus (Patho) enzyme-linked immunosorbent assay (ELISA) kits for the rapid diagnosis of active tuberculosis (TB) and to distinguish between active TB and non-TB pulmonary diseases in Tunisian patients.
DESIGN: Immunoglobulin G mediated humoral immune response against mycobacterial antigens (38 kDa and lipoarabinomannan, Myco G; 16 and 38 kDa, Patho) was evaluated in a group of active TB patients (128 smear-positive pulmonary and 33 extra-pulmonary samples) and in a control group (107 patients with non-tuberculous lung disease and two with leprosy). Active TB cases were confirmed by Mycobacterium tuberculosis culture from clinical samples.
RESULTS: The sensitivity of the Myco G test was 71% in active TB (pulmonary and extra-pulmonary), while the specificity was 100%. The Patho test showed a sensitivity of 43.5% with a specificity of 96.3%. A combination of both tests showed a sensitivity of 81% and a specificity of 96.3%.
CONCLUSIONS: Both ELISA tests were simple and easy to perform. Their combined use led to an increase in the diagnostic accuracy of active TB and its discrimination from non-TB pulmonary diseases. They could therefore be used as screening tools in poorly equipped laboratories in TB-endemic regions.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20550766

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  8 in total

1.  Immunochromatographic IgG/IgM test for rapid diagnosis of active tuberculosis.

Authors:  Walid Ben-Selma; Hedi Harizi; Jalel Boukadida
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

2.  Evaluation of antigen detection test (chromatographic immunoassay): potential to replace the antibody assay using purified 45-kDa protein for rapid diagnosis of tuberculosis.

Authors:  Alireza Hadizadeh Tasbiti; Ahmadreza Bahrmand; Mohammad Ali Shokrgozar; Mostafa Ghanei; Mostafa Ghanaie; Abolfazl Fateh; Ali Karimi; Shamsi Yari
Journal:  J Clin Lab Anal       Date:  2013-12-27       Impact factor: 2.352

3.  A systematic review of biomarkers to detect active tuberculosis.

Authors:  Emily MacLean; Tobias Broger; Seda Yerlikaya; B Leticia Fernandez-Carballo; Madhukar Pai; Claudia M Denkinger
Journal:  Nat Microbiol       Date:  2019-02-25       Impact factor: 17.745

4.  Protein array identification of protein markers for serodiagnosis of Mycobacterium tuberculosis infection.

Authors:  Fangbin Zhou; Xindong Xu; Sijia Wu; Xiaobing Cui; Lin Fan; Weiqing Pan
Journal:  Sci Rep       Date:  2015-10-20       Impact factor: 4.379

5.  Influence of HLA-DRB1 Alleles on the Variations of Antibody Response to Tuberculosis Serodiagnostic Antigens in Active Tuberculosis Patients.

Authors:  Fangbin Zhou; Xindong Xu; Sijia Wu; Xiaobing Cui; Lin Fan; Weiqing Pan
Journal:  PLoS One       Date:  2016-10-27       Impact factor: 3.240

6.  Glutaraldehyde test for the rapid diagnosis of pulmonary and extra-pulmonary tuberculosis in an area with high tuberculosis incidence.

Authors:  Ben Hadj Hassine Ahmed; Marzouk Manel; Dhaou Mohamed; Boukadida Jalel
Journal:  Mem Inst Oswaldo Cruz       Date:  2017-11       Impact factor: 2.743

7.  Mycobacterium tuberculosis Secreted Proteins As Potential Biomarkers for the Diagnosis of Active Tuberculosis and Latent Tuberculosis Infection.

Authors:  Caiqin Zhang; Xiaoqin Song; Yong Zhao; Hai Zhang; Shanmin Zhao; Fengfeng Mao; Bing Bai; Shaoping Wu; Changhong Shi
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

Review 8.  A systematic review of potential screening biomarkers for active TB disease.

Authors:  James H Wykowski; Chris Phillips; Thao Ngo; Paul K Drain
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2021-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.